These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27575928)

  • 1. Caution with the use of the new direct acting antivirals in the hepatitis C virus related renal disease.
    Gomis A; Díaz M; de Lorenzo A; Ruiz-Roso G; Liaño F
    Nefrologia; 2016; 36(6):713-715. PubMed ID: 27575928
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of direct-acting antivirals for the treatment of hepatitis C in patients with advanced chronic kidney disease.
    Maruyama A; Partovi N; Yoshida EM; Erb SR; Azalgara VM; Hussaini T
    Nephrol Dial Transplant; 2017 Jan; 32(1):35-41. PubMed ID: 26481484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of direct-acting antivirals-based antiviral therapies for hepatitis C virus patients with stage 4-5 chronic kidney disease: a meta-analysis.
    Li T; Qu Y; Guo Y; Wang Y; Wang L
    Liver Int; 2017 Jul; 37(7):974-981. PubMed ID: 27943605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection in maintenance hemodialysis patients: recommendations for diagnostics and treatment.
    Dzekova-Vidimliski P; Sikole A
    Int J Artif Organs; 2017 Feb; 39(12):590-595. PubMed ID: 28165585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating hepatitis B virus/hepatitis C virus coinfected patients with direct-acting hepatitis C virus antivirals only is not safe.
    Ozaras R; Sunbul M; Parlak M; Bodur H; Leblebicioglu H
    Hepatology; 2016 Nov; 64(5):1825-1827. PubMed ID: 27043022
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of Direct-Acting Antivirals Compared with Older Agents for Hepatitis C.
    Ta K; Zehtabchi S
    Am Fam Physician; 2017 Jun; 95(11):Online. PubMed ID: 28671433
    [No Abstract]   [Full Text] [Related]  

  • 7. [Predictive factors of response to Direct Acting Antivirals therapy Drug resistance hepatitis C virus].
    Suda G; Yamasaki K; Sakamoto N
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():189-92. PubMed ID: 26845928
    [No Abstract]   [Full Text] [Related]  

  • 8. New and Emerging Evidence on the Use of Second-Generation Direct Acting Antivirals for the Treatment of Hepatitis C Virus in Renal Impairment.
    Sorbera MA; Friedman ML; Cope R
    J Pharm Pract; 2017 Jun; 30(3):359-365. PubMed ID: 26902648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and important drug-drug interactions to remember when treating advanced chronic kidney disease patients with hepatitis C direct acting anti-viral therapy.
    Cohen E; Liapakis A
    Semin Dial; 2019 Mar; 32(2):141-151. PubMed ID: 30557903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic update in hepatitis C].
    Devesa MJ; Cuenca F; Izquierdo S; Sánchez-Pobre P; Ladero JM; López-Alonso G; Díaz-Rubio M; Rey E
    Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():48-51. PubMed ID: 26365735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial commentary: Management of hepatitis C Virus in HIV-infected patients in the era of direct-acting antivirals.
    Zeremski M; Martinez AD; Talal AH
    Clin Infect Dis; 2014 Mar; 58(6):880-2. PubMed ID: 24336913
    [No Abstract]   [Full Text] [Related]  

  • 12. Pre- Versus Posttransplant Treatment of Hepatitis C Virus With Direct-Acting Antivirals in Liver Transplant Recipients: More Issues to be Solved.
    Abdelqader A; Kabacam G; Woreta TA; Hamilton JP; Luu H; Al Khalloufi K; Saberi B; Philosophe B; Cameron AM; Gurakar A
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):1-5. PubMed ID: 28260422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing hepatitis C virus-HIV liver transplant recipients with the new direct-acting antivirals: are we glimpsing a brilliant future behind our shoulders?
    Fagiuoli S; Puoti M; Rizzardini G
    AIDS; 2016 Jan; 30(2):323-5. PubMed ID: 26684824
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD.
    Sise ME; Backman E; Ortiz GA; Hundemer GL; Ufere NN; Chute DF; Brancale J; Xu D; Wisocky J; Lin MV; Kim AY; Thadhani R; Chung RT
    Clin J Am Soc Nephrol; 2017 Oct; 12(10):1615-1623. PubMed ID: 28882857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The era of direct-acting antivirals has begun: the beginning of the end for HCV?
    Vachon ML; Dieterich DT
    Semin Liver Dis; 2011 Nov; 31(4):399-409. PubMed ID: 22189979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on the management of hepatitis C virus-infected patients with stage 4-5 chronic kidney disease while awaiting the revised KDIGO Guidelines.
    Pol S; Jadoul M; Vallet-Pichard A
    Nephrol Dial Transplant; 2017 Jan; 32(1):32-35. PubMed ID: 27005992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-drug interactions with direct-acting antivirals - less is more.
    Wong GL
    Clin Mol Hepatol; 2021 Jan; 27(1):81-82. PubMed ID: 33317241
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct-acting antivirals in hepatitis C virus-positive mantle cell lymphomas.
    Merli M; Marino D; Cencini E; Rattotti S; Fraenza C; Grossi P; Bianchi B; Mora B; Sciarra R; Finotto S; Mecacci B; Passamonti F; Visco C; Arcaini L
    Hematol Oncol; 2021 Apr; 39(2):263-266. PubMed ID: 33150988
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals.
    Ippolito G; Antonelli G
    Clin Microbiol Infect; 2016 Oct; 22(10):824-825. PubMed ID: 27863749
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis C Virus Infection in Kidney Transplant Patients: Current Treatment Options.
    Dzekova-Vidimliski P; Sikole A
    Exp Clin Transplant; 2017 Dec; 15(6):587-593. PubMed ID: 29219790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.